1. Home
  2. VSEC vs IMVT Comparison

VSEC vs IMVT Comparison

Compare VSEC & IMVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VSEC
  • IMVT
  • Stock Information
  • Founded
  • VSEC 1959
  • IMVT 2018
  • Country
  • VSEC United States
  • IMVT United States
  • Employees
  • VSEC N/A
  • IMVT N/A
  • Industry
  • VSEC Military/Government/Technical
  • IMVT Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • VSEC Consumer Discretionary
  • IMVT Health Care
  • Exchange
  • VSEC Nasdaq
  • IMVT Nasdaq
  • Market Cap
  • VSEC 2.7B
  • IMVT 2.8B
  • IPO Year
  • VSEC N/A
  • IMVT N/A
  • Fundamental
  • Price
  • VSEC $130.40
  • IMVT $16.05
  • Analyst Decision
  • VSEC Strong Buy
  • IMVT Buy
  • Analyst Count
  • VSEC 6
  • IMVT 10
  • Target Price
  • VSEC $125.17
  • IMVT $40.14
  • AVG Volume (30 Days)
  • VSEC 232.1K
  • IMVT 1.4M
  • Earning Date
  • VSEC 07-30-2025
  • IMVT 08-05-2025
  • Dividend Yield
  • VSEC 0.31%
  • IMVT N/A
  • EPS Growth
  • VSEC N/A
  • IMVT N/A
  • EPS
  • VSEC 0.67
  • IMVT N/A
  • Revenue
  • VSEC $1,173,794,000.00
  • IMVT N/A
  • Revenue This Year
  • VSEC $3.14
  • IMVT N/A
  • Revenue Next Year
  • VSEC $11.58
  • IMVT N/A
  • P/E Ratio
  • VSEC $195.56
  • IMVT N/A
  • Revenue Growth
  • VSEC 40.70
  • IMVT N/A
  • 52 Week Low
  • VSEC $73.36
  • IMVT $12.72
  • 52 Week High
  • VSEC $140.64
  • IMVT $34.47
  • Technical
  • Relative Strength Index (RSI)
  • VSEC 42.29
  • IMVT 58.01
  • Support Level
  • VSEC $133.84
  • IMVT $15.26
  • Resistance Level
  • VSEC $140.57
  • IMVT $16.14
  • Average True Range (ATR)
  • VSEC 4.88
  • IMVT 0.76
  • MACD
  • VSEC -0.87
  • IMVT 0.02
  • Stochastic Oscillator
  • VSEC 21.28
  • IMVT 62.99

About VSEC VSE Corporation

VSE Corp is a diversified aftermarket products and services company providing repair services, parts distribution, logistics, supply chain management, and consulting services for land, sea, and air transportation assets to commercial and government markets. Its operations include supply chain management solutions, parts supply and distribution, and maintenance, repair, and overhaul (MRO) services for vehicle fleet, aviation, maritime and other customers. Its reportable segments are; Aviation and Fleet. The majority of the revenue for the company is generated from the Aviation segment which is a provider of aftermarket parts distribution and MRO services for components and engine accessories supporting commercial, business, and general aviation operators.

About IMVT Immunovant Inc.

Immunovant Inc is a clinical-stage immunology company dedicated to enabling normal lives for people with autoimmune diseases. Its focus is on developing IMVT-1402, a potential inhibitor of the neonatal fragment crystallizable receptor (FcRn), to address autoimmune diseases driven by high levels of pathogenic immunoglobulin G (IgG) antibodies. FcRn is involved in preventing the degradation of IgG antibodies, and inhibition of FcRn has been shown to reduce levels of total IgG and pathogenic IgG antibodies. The company operates in a single operating segment, which includes all activities related to the research, development and manufacturing of its product candidates.

Share on Social Networks: